Kuang, Yehong
Li, Yuzhen
Lv, Chengzhi
Li, Min
Zhang, Zhenying
Chen, Yi
Chen, Wendong
Wang, Xingzhi
Ba, Lina
Zhong, Yichen
Feldman, Steven
Funding for this research was provided by:
Bristol Myers Squibb
Article History
Received: 21 February 2024
Accepted: 3 April 2024
First Online: 11 May 2024
Declarations
:
: Yi Chen and Wendong Chen are the employees of Changsha Normin Medical Technology Ltd, which received funding from Bristol Myers Squibb to conduct this study. Xingzhi Wang, Lina Ba, and Yichen Zhong are the employees of Bristol Myers Squibb. Yehong Kuang, Yuzhen Li, Chengzhi Lv, Min Li, Zhenying Zhang, and Steven Feldman have nothing to disclose.
: This study was reviewed and approved by the ethics committee boards of Xiangya Hospital of Central South University (approval #202212843), The Second Affiliated Hospital of Harbin Medical University (approval #KY2023-010), Dalian Dermatological Diseases Hospital (approval #KY2003-001), Dushu Lake Hospital of Suzhou University (approval #230058), and the 8th Affiliated Hospital of Zhongshan University (approval #2023-015-01). This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. All included patients and dermatologists signed a formal consent form to participate in this study and allow publication of the results.